The South Florida Water Management District is now rewarding hunters for removing python eggs and active nests from the ...
The Detroit Zoo is one of only two zoos in the U.S. that has a dedicated center for amphibians separate from reptiles.
Rosalind, a Rust-built genomics library, runs whole genome sequencing analysis in 100 MB of RAM on a laptop, with no cloud upload required. The project launched May 27, 2026 — days after the 23andMe b ...
A risk-taking outsider, he brought speed, competition and controversy to one of science’s biggest races. By Nicholas Wade J. Craig Venter, a scientist and entrepreneur who raced to decode the human ...
Abstract: In this work, a genetic algorithm, implemented in the Python programming language, is developed to model a DCDC buck converter in discrete-time. The modeling is performed and validated using ...
In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...
Florida's Python Elimination Program pays certified hunters to remove the invasive snakes from the Everglades. Burmese pythons have caused a severe decline in native small mammal populations in South ...
Program to expand access to exome sequencing to help clinicians confirm diagnosis and guide clinical decision-making in NPC GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving ...
A new study has uncovered new genetic rules that determine how CD8 “killer” T cells choose between becoming long-lasting, protective immune cells or slipping into exhausted, dysfunctional states.
NEW YORK CITY (WABC) -- New York City is launching a groundbreaking program to prevent sudden deaths. The city's medical examiner will offer free genetic screening to at-risk family members of people ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Chicago philanthropists Don and Anne Edwards have donated ...
After its cannabidiol gel candidate failed a phase 3 trial in fragile X syndrome, Harmony Biosciences has now paused development of the asset in a different genetic disease. Harmony announced in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results